Signs of success in delaying onset of drug-resistant gonorrhoea in UK

April 11, 2014

Gonorrhoea threatens to become resistant to all of the antibiotics used to treat it. Today, Professor Cathy Ison will explain that campaigns in the UK to raise awareness of drug resistance among healthcare professionals, policy-makers and at risk groups have shown some success in delaying the onset of treatment failure

In 2012, there were over 25,000 cases of gonorrhoea in the UK making it the second most common bacterial after chlamydia. Control of gonorrhoea is dependent on successful antibiotic treatment, as the bacterium that causes the infection, Neisseria gonorrhoeae, has become increasingly resistance to every antibiotic used to treat it over the last 60 years. Today, at the Society for General Microbiology's Annual Conference in Liverpool, Professor Cathy Ison explains the challenges facing the treatment of the disease, which threatens to become resistant to all antibiotics.

In 2012, Professor Ison led on the launch of the Health Protection Agency's first Gonorrhoea Resistance Action Plan for England and Wales, as part of the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) that provides on levels of . GRASP, which has provide surveillance data in England and Wales since 2000, has been used to change clinical practice in the UK.

Today, she will show that campaigns in the UK to raise awareness of drug resistance among , policy-makers and at risk groups have shown some success in delaying the onset of to the oral antibiotic cefixime. When evidence of antibiotic-resistance to cefixime was identified it was replaced as treatment of choice by ceftriaxone, an injectable antibiotic of the same class. This was done to prevent the widespread emergence of cefixime-resistance gonorrhoea. Cefixime and ceftriaxone are the last group of antibiotics known to be fully effective against gonorrhoea.

Professor Ison said: "While we have shown that a proactive approach to changing therapy has shown some success, we should remember that this infection has repeatedly become resistant to successive antibiotics over decades, and that it is likely that this is only a temporary reprieve. This will give the internationally community time to investigate new drugs and alternative strategies for treating gonorrhoea and maintain it as a treatable infection."

However, Professor Ison stresses that we should remain vigilant: "We can already see in data from England and Wales, as well as other some countries, that there is the beginning of drifts towards resistance to the injectable drug, ceftriaxone, which is currently used as the drug of choice for gonorrhoea. Public health control of gonorrhoea must include prompt diagnosis, delivery of effective treatment and detection of treatment failures, combined with strong prevention messages."

To combat the continuing high rates of STI transmission in England, and the growing risk of gonorrhoea treatment failure it is essential that individuals: 

  • Always use a condom when having sex with new and casual partners
  • Reduce the number of sexual partners and avoid overlapping sexual relationships
  • Get a regular STI check-up if having unprotected sex with new or casual partners.

Explore further: Last-line antibiotics increasingly ineffective against gonorrhea

Related Stories

Last-line antibiotics increasingly ineffective against gonorrhea

June 10, 2013
The last remaining antibiotics used to treat gonorrhea (cefixime and ceftriaxone) in England and Wales are becoming less effective. But recent changes in prescribing practice, based on new recommendations that challenge previous ...

Researchers develop new methods to keep resistant gonorrhoea in check

March 11, 2014
(Medical Xpress)—A pandemic of super-resistant gonorrhoea could be kept in check using new methods to track outbreaks of the disease, according to a University of Queensland infectious diseases expert.

Is there a way to slow the process of bacterial antibiotic resistance?

April 10, 2014
Continually under attack by noxious substances in their environments, bacteria have developed many clever mechanisms to survive. When confronted with an antibiotic, they can destroy it with enzymes, rendering it harmless. ...

STIs and risky sex still an issue

November 26, 2013
New results from the third National Survey of Sexual Attitudes and Lifestyles (Natsal), published in The Lancet, provide a picture of sexually transmitted infection (STI) prevalence and testing, uptake of sexual health interventions ...

Chlamydia and gonorrhoea infections linked to pregnancy complications

September 4, 2013
Becoming infected with chlamydia or gonorrhoea in the lead-up to, or during, pregnancy, increases the risk of complications, such as stillbirth or unplanned premature birth, indicates research published online in the journal ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.